---
title: "Innovent licenses IBI355 rights to Spero for up to $1.1bn"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292739699.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-07-15T09:01:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292739699.md)
  - [en](https://longbridge.com/en/news/292739699.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292739699.md)
generator: "portal-rs"
---

# Innovent licenses IBI355 rights to Spero for up to $1.1bn

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [01801.HK](https://longbridge.com/en/quote/01801.HK.md)
- [SPRO.US](https://longbridge.com/en/quote/SPRO.US.md)

## Related News & Research

- [Innovent Biologics Grants Share Options and Restricted Shares Under 2024 Scheme](https://longbridge.com/en/news/297677279.md)
- [Innovent Biologics files list of board, board committee members with disclosure duties](https://longbridge.com/en/news/297651124.md)
- [Innovent Biologics grants 583,731 restricted shares under 2024 share scheme](https://longbridge.com/en/news/297669209.md)
- [Spero Therapeutics issues 102,000 RSUs, 67,600 options to new hires under inducement plan](https://longbridge.com/en/news/297952743.md)
- [CLSA: China Biotech Fundamentals Remain Solid; Top Picks BEONE MEDICINES , INNOVENT BIO  and LEADS BIOLABS-B](https://longbridge.com/en/news/297994035.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**